Alchemab Therapeutics unveils Alzheimer’s candidate ATLX-1088 targeting CD33 at the Antibody Industrial Symposium
Collagen Peptides Market worth $922 million by 2028
Polyplastics Announces Commercial Availability of DURACON (R) POM PM Series for Medical Industry
Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics
America’s Best Wings: Everything You Need to Know
Punishments, intimidation, employees under pressure … A toxic atmosphere denounced at the Lomagne hospital
Sunscreen: index, category of protection, quantity… 3 things to know to choose it well
Summer and raw vegetables – ladepeche.fr
Hospital Centre: reasons for hope!
The Blood Donor Association thanks donors
CAMBRIDGE, England, June 22, 2023 /PRNewswire/ — Alchemab Therapeutics, an antibody discovery company identifying naturally occurring antibodies from individuals resilient to disease, today announced that it...